Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
11.29
-0.20 (-1.74%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Cellebrite DI Revenue
Cellebrite DI had revenue of $131.14M in the quarter ending June 30, 2026, with 15.77% growth. This brings the company's revenue in the last twelve months to $514.29M, up 17.76% year-over-year. In the year 2025, Cellebrite DI had annual revenue of $475.68M with 18.56% growth.
Revenue (ttm)
$514.29M
Revenue Growth
+17.76%
P/S Ratio
5.51
Revenue / Employee
$400,225
Employees
1,285
Market Cap
2.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 475.68M | 74.47M | 18.56% |
| Dec 31, 2024 | 401.20M | 76.09M | 23.41% |
| Dec 31, 2023 | 325.11M | 54.46M | 20.12% |
| Dec 31, 2022 | 270.65M | 24.41M | 9.91% |
| Dec 31, 2021 | 246.25M | 51.33M | 26.34% |
| Dec 31, 2020 | 194.91M | 23.06M | 13.42% |
| Dec 31, 2019 | 171.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Euronet Worldwide | 4.37B |
| Teradata | 1.69B |
| Five9 | 1.20B |
| Calix | 1.11B |
| Csquare | 1.06B |
| NetScout Systems | 883.16M |
| Appian | 795.31M |
| AvePoint | 466.15M |
CLBT News
- 1 day ago - Kaplan Fox Notifies Cellebrite DI Ltd. (CLBT) Investors of a Securities Investigation into the Company - Newsfile Corp
- 6 days ago - Kaplan Fox Announces a Securities Investigation into Cellebrite DI Ltd. (CLBT) - Investors Encouraged to Contact the Firm - Newsfile Corp
- 6 days ago - Cellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global Markets - PRNewsWire
- 9 days ago - Cellebrite says Shiven Ramji to succeed Thomas Hogan as CEO - TheFly
- 9 days ago - Cellebrite falls -35.7% - TheFly
- 9 days ago - Cellebrite falls -31.8% - TheFly
- 9 days ago - Cellebrite price target lowered to $15 from $23 at TD Cowen - TheFly
- 9 days ago - Cellebrite price target lowered to $16 from $20 at JPMorgan - TheFly